Filing Details

Accession Number:
0001104659-23-099294
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-08 16:08:31
Reporting Period:
2023-09-06
Accepted Time:
2023-09-08 16:08:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263136 J William Peters C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Cfo, Evp & Treasurer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-06 10,000 $19.79 115,603 No 4 M Direct
Common Stock Acquisiton 2023-09-06 21,250 $20.23 136,853 No 4 M Direct
Common Stock Acquisiton 2023-09-06 25,250 $13.03 162,103 No 4 M Direct
Common Stock Disposition 2023-09-06 60,684 $51.75 101,419 No 4 S Direct
Common Stock Disposition 2023-09-06 59 $52.26 101,360 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2023-09-06 10,000 $0.00 10,000 $19.79
Common Stock Employee Stock Option (right to buy) Disposition 2023-09-06 21,250 $0.00 21,250 $20.23
Common Stock Employee Stock Option (right to buy) Disposition 2023-09-06 25,250 $0.00 25,250 $13.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,053 2028-03-15 No 4 M Direct
36,475 2029-03-15 No 4 M Direct
69,100 2030-03-16 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.26 to $52.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.26 to $52.265, inclusive.
  4. Shares subject to the option are fully vested and immediately exercisable.
  5. Shares subject to the option vest in four equal annual installments beginning on March 16, 2021.